Dr. د.صهيب الكمالي

Professional Profile and Career

Dr. Sohaib Al-Kamali is a distinguished authority in the fields of Hematology and Medical Oncology, possessing over 15 years of intensive clinical experience. Serving as a Senior Consultant at PulseHospital, he is recognized for his commitment to precision medicine and compassionate patient care. His career is characterized by the implementation of evidence-based oncology protocols and a patient-centric approach that ensures both physical and psychological well-being throughout the treatment journey.

Subspecialties and Clinical Interests

Dr. Al-Kamali specializes in the diagnosis and management of complex blood disorders and malignancies, including:
- Acute and Chronic Leukemias.
- Lymphomas (Hodgkin and Non-Hodgkin).
- Coagulation disorders and hereditary blood syndromes.
- Aplastic anemia and bone marrow failure disorders.
- Multiple Myeloma and plasma cell dyscrasias.

Clinical Procedures and Interventions

Dr. Al-Kamali oversees a spectrum of advanced clinical interventions, including:
- Bone marrow biopsies and aspiration with comprehensive histological analysis.
- Administration of targeted chemotherapy and biological therapy regimens.
- Management of autologous and allogeneic stem cell transplantation protocols.
- Advanced immunotherapy treatments to boost the body's natural defense against malignancy.
- Intrathecal chemotherapy administration for central nervous system-involved malignancies.

Advanced Diagnostic Technologies

At PulseHospital, Dr. Al-Kamali utilizes state-of-the-art diagnostic tools to ensure the highest standard of accuracy:
- Flow Cytometry for high-resolution hematological cellular analysis.
- Cytogenetic and Molecular testing to identify specific genomic mutations.
- PET-CT fusion imaging for precise staging of lymphomas and solid tumors.
- Next-Generation Sequencing (NGS) to enable personalized, mutation-specific treatment plans.

Clinical Guidelines for Patients

Dr. Al-Kamali emphasizes critical patient preparation:
- Pre-treatment: Maintaining an optimal nutritional status is paramount. Patients must undergo baseline cardiac and renal function tests to ensure they are candidates for intensive systemic therapy.
- Post-treatment: Strict adherence to infection control measures is mandatory due to temporary immunosuppression. Regular monitoring of complete blood counts (CBC) is essential to guide long-term maintenance therapy.

Frequently Asked Questions (FAQ)

• Q: Does every diagnosis of a blood disorder indicate cancer? A: No; many hematological conditions are benign and require observation rather than aggressive intervention.
• Q: How long is the treatment duration? A: The duration is highly individualized based on the disease subtype and molecular profile. Each patient is provided with a tailored roadmap.
• Q: What are the red-flag symptoms for blood disorders? A: Unexplained fatigue, unintentional weight loss, persistent lymph node swelling, or recurring bruising should be evaluated immediately by a specialist.